Table 6
Agreement on sex and date of birth between Discharge Abstract Database (DAD) and Canadian Cancer Registry (CCR) for DAD records linking during follow-up, by type of cancer and province (excluding Quebec), 2005 to 2008

Table 6
Agreement on sex and date of birth between Discharge Abstract Database (DAD) and Canadian Cancer Registry (CCR) for DAD records linking during follow-up, by type of cancer and province (excluding Quebec), 2005 to 2008
Table summary
This table displays the results of Agreement on sex and date of birth between Discharge Abstract Database (DAD) and Canadian Cancer Registry (CCR) for DAD records linking during follow-up. The information is grouped by Type of cancer and linkage characteristics (appearing as row headers), Newfoundland and Labrador, Prince Edward Island, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta and British Columbia (appearing as column headers).
Type of cancer and linkage characteristics Newfoundland and Labrador Prince Edward Island Nova Scotia New Brunswick Ontario Manitoba Saskatchewan Alberta British Columbia
Prostate  
Number of linked DAD records 4,032 1,003 7,727 5,779 35,771 4,403 7,789 9,359 22,391
% agreeing with CCR sex 100.0 99.9 100.0 99.9 100.0 100.0 100.0 100.0 100.0
% agreeing with CCR date of birth 98.6 95.8 98.9 98.7 99.6 97.3 98.2 98.8 99.0
Female breast  
Number of linked DAD records 3,085 747 6,613 4,312 25,303 6,241 6,565 9,641 21,514
% agreeing with CCR sex 100.0 99.9 99.9 99.8 100.0 100.0 100.0 100.0 99.9
% agreeing with CCR date of birth 97.8 98.9 99.0 99.4 99.7 98.7 99.1 99.5 99.3
Colorectal  
Number of linked DAD records 7,800 1,240 9,579 4,631 49,317 9,752 8,940 12,478 29,306
% agreeing with CCR sex 99.9 99.9 100.0 99.3 100.0 99.9 100.0 100.0 99.8
% agreeing with CCR date of birth 98.6 97.2 99.0 99.4 99.7 98.1 97.6 99.3 99.1
Lung  
Number of linked DAD records 3,455 1,290 7,656 7,351 50,168 7,391 7,374 12,191 24,416
% agreeing with CCR sex 99.7 99.8 99.9 99.9 100.0 99.9 100.0 100.0 99.8
% agreeing with CCR date of birth 97.5 96.4 98.8 98.8 99.6 97.2 97.6 99.0 99.0
Note: Follow-up period for colorectal, lung and female breast cancers extended from 31 days before to 365 days after CCR date of diagnosis; for prostate cancer, follow-up extended from 31 days before to 730 days after date of diagnosis.
Source: Canadian Cancer Registry data file, April 4, 2012; Discharge Abstract Database, fiscal years 2004/2005 to 2010/2011.

Date modified: